Skip to content

Eikon Therapeutics, Inc. EIKN Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

MYR Group logo
MYR GroupMYRG
$8.38M-42.1%
Cabot Corporation logo
Cabot CorporationCBT
$239M-3.2%
Belden logo
BeldenBDC
$37.33M-9.6%
HES
Hess MidstreamHESM
$23.7M+37.0%
NNN REIT logo
NNN REITNNN
$100.58M+1.7%
Repligen logo
RepligenRGEN
$16.76M-1.9%

Other financials

Income statement

See full
Operating income-$87.3M-22.3%
Net income-$83.0M-21.6%
EPS (diluted)-$2.46+90.9%

Balance sheet

See full
Cash & equivalents$161.2M-21.2%
Total debt$254.8M
Total equity$550.7M+186%
Total assets$850.8M

Cash flow

See full
Operating cash flow-$89.8M-64.7%
CapEx$262.0K-98.8%
Free cash flow-$90.1M-17.1%

Valuation

See full
Market cap$521.35M

Where this comes from

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eikon Therapeutics, Inc. 's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eikon Therapeutics, Inc. 's other non-current liabilities?
Eikon Therapeutics, Inc. (EIKN) reported other non-current liabilities of $10M in Q1 2026.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.